| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |